Introduction: The number of venous interventions continues to rise. The outcome of venous procedures is related to appropriate stent selection and implantation.
Aim: To compare the usefulness of magnetic resonance imaging (MRI) and intravascular ultrasound (IVUS) in the determination of target vein section area (VSA) as techniques for selecting an appropriate diameter for a venous stent.
Material And Methods: VSAs of iliac and common femoral veins obtained in contrast-enhanced MRI (CE-MRI) and non-contrast-enhanced MRI (NCE-MRI) were calculated for 18 consecutive patients with post-thrombotic syndrome (PTS), and VSAs obtained using IVUS were calculated for 15 of these PTS patients.
Results: The differences in iliac and common femoral vein VSAs obtained using CE-MRI and NCE-MRI were small and not clinically significant. VSAs of vessels obtained using CE-MRI and NCE-MRI correlated significantly with each other, with values in the range 0.87-0.97 and -values < 0.001. However, no significant relationships were found between section areas measured using MRI and IVUS and the differences in measurements was, on average, to 60%.
Conclusions: CE magnetic resonance venography can be replaced by Dixon-based NCE-MRI in the preoperative evaluation of patients with PTS who qualify for venous intervention. However, CE-MRI and NCE-MRI performed for ipsilateral and contralateral extremities are not sufficient for appropriate venous stent selection, and IVUS remains a necessary tool in determining venous intervention in iliac veins.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6777183 | PMC |
http://dx.doi.org/10.5114/aic.2019.87889 | DOI Listing |
J Surg Case Rep
January 2025
Department of Hepatobiliary Surgery, YiChun City People's Hospital, 1061 Jinxiu Avenue, Yichun 336000, Jiangxi, China.
This case report describes a 66-year-old male diagnosed with a giant retroperitoneal lymphangioma, presenting with an abdominal mass confirmed via magnetic resonance imaging (MRI). Laparoscopic surgery was successfully performed to excise the mass, with histopathological examination confirming the diagnosis. The patient's postoperative recovery was uneventful, with no signs of recurrence or metastasis observed at the three-month follow-up.
View Article and Find Full Text PDFEClinicalMedicine
February 2025
Department of Neurosurgery, King's College Hospital Foundation Trust, London, UK.
Background: Supratentorial function-eloquent brain tumour surgeries challenge the balance between maximal tumour resection and preservation of neurological function. This study aims to evaluate the efficacy of preoperative and intraoperative mapping techniques on resection outcomes and post-operative deficits.
Methods: This systematic review and meta-analysis examined literature up to March 2023, sourced from PubMed, Embase, and Medline.
World J Clin Oncol
January 2025
Department of Hematology, The First Affiliated Hospital of Jishou University, Jishou 416000, Hunan Province, China.
Background: Extramedullary plasmacytoma (EMP) represents one of the rarer forms of plasma cell malignancies, capable of impacting a variety of tissues and organs throughout the body. The majority of EMP cases are predominantly found in the head and neck region, especially within the laryngopharynx, as well as in the gastrointestinal tract. While there have been documented instances of oropharyngeal involvement in EMP cases in the academic literature, it is important to note that EMP specifically affecting the uvula is exceedingly uncommon.
View Article and Find Full Text PDFClin Transl Radiat Oncol
March 2025
University Medical Center Utrecht, Department of Radiation Oncology, Utrecht, the Netherlands.
Background And Purpose: This study assessed the treatment time of online adaptive (i.e. Adapt-to-Shape, ATS) and virtual couch shift (i.
View Article and Find Full Text PDFFront Pediatr
January 2025
Department of Pediatric Cardiology, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China.
Background: Blue rubber bleb nevus syndrome (BRBNS) is a rare venous malformation disorder. Currently, there is no standard therapy for this disease. However, lauromacrogol, a sclerosant extensively utilized in the management of vascular malformations, has been applied in the treatment of BRBNS.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!